MB-CART2019.1 Clinical Trials
4 recruitingBiologic
Phase 23Not Applicable1Phase 11
Showing 1–4 of 4 trials
Recruiting
Phase 2
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Diffuse Large B Cell Lymphoma
Miltenyi Biomedicine GmbH213 enrolled51 locationsNCT04844866
Recruiting
Phase 1Phase 2
MB-CART2019.1 in Refractory Multiple Sclerosis
Multiple SclerosisCAR-T Cell Therapy
Miltenyi Biomedicine GmbH26 enrolled1 locationNCT07178431
Recruiting
Phase 2
DALY II Japan/MB-CART2019.1 for DLBCL
DLBCL - Diffuse Large B Cell LymphomaCAR-T Cell Therapy
Miltenyi Biomedicine GmbH31 enrolled5 locationsNCT07288879
Recruiting
Not Applicable
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
Melanoma Stage IVPediatric ALLMelanoma Stage III+4 more
Miltenyi Biomedicine GmbH40 enrolled7 locationsNCT06508775